GlassScriptPhysician profile
Elizabeth C Fallon
NPI 1710166673
$1,343.68
in general payments reported to CMS, 2019-2025
15 companies · $976 in 2025
The $976 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $308 · 2024: $59.80 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $307.58 | 2022 | |
| Intera Oncology, INC | $169.32 | 2025 | Intera |
| Exelixis INC. | $120.85 | 2025 | Cabometyx |
| Abbvie INC. | $120.17 | 2025 | |
| Springworks Therapeutics, INC. | $113.76 | 2025 | Ogsiveo |
| Astrazeneca Pharmaceuticals LP | $113.42 | 2024-2025 | |
| Tempus Ai, INC | $107.65 | 2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $107.53 | 2025 | |
| Intuitive Surgical, INC. | $36.75 | 2024 | |
| Immunocore Limited | $28.34 | 2025 | Kimmtrak |
| Tersera Therapeutics LLC | $28.30 | 2025 | Zoladex |
| Boston Scientific Corporation | $27.51 | 2025 | Axonics |
| Pharmacosmos Therapeutics INC. | $24.03 | 2025 | Monoferric |
| Blueprint Medicines Corporation | $20.84 | 2025 | Ayvakit |
| Alexion Pharmaceuticals, INC. | $17.63 | 2025 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Fallon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.